Gheuens Sarah bought AGIO
July 1, 2025 · Form 4 insider transaction
Gheuens Sarah bought 8,374 shares of Agios Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,374
Price
$0.00
Total value
N/A
InsiderGheuens Sarah
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateJuly 1, 2025
Filing dateJuly 3, 2025
Shares owned after65,362
OwnershipDirect
10b5-1 planNo
AmendedNo